About Meds GHK-Cu

The name Meds GHK-Cu

Meds GHK-Cu is a collection of articles about a copper peptide. There is no medical practice behind the name: the site cannot issue prescriptions or arrange appointments, and no medicine is sold or dispatched here. Medical advice and personal treatment decisions are outside what these pages can provide.

The point where a useful name starts hiding too much interests me. GHK, GHK-Cu, Copper Tripeptide-1 and a related copper peptide can arrive in the same conversation, carrying results from quite different experiments. The chemistry becomes clearer when the ingredients come back into view.

The name “meds” makes that question particularly pressing. A cosmetic ingredient can acquire the air of an established medicine without the human trials that would support the larger claim. The small, precise experiments have my sympathy because they leave a reader knowing something concrete.

Why the formulations matter

The AHK-Cu follicle experiment is a good example of the puzzle. Human tissue, a related peptide, a result outside the body: each fact changes what can fairly be said. The trial of GHK with 5-aminolevulinic acid raises another question about which ingredient did how much.

I am not disappointed that a promising result has qualifications. Often the qualification is where the interesting next experiment begins. Hold the carrier constant. Separate the ingredients. Measure a change people can notice. Follow the harms as carefully as the hoped-for effects.

Copper Tripeptide-1 is the cosmetic name for GHK-Cu, as described in the topical literature. That is a useful translation; it still leaves a particular cream's formulation to be investigated. The name on the discussion and the contents of the experiment need to meet.

Errors and unresolved questions

A wrong peptide name can send an otherwise accurate explanation in the wrong direction. If a sentence here does that, I want the correction. The contact page describes the information needed for a correction and the current lack of a public submission route.

The reading list includes some related-peptide studies because they explain where claims come from. Their presence leaves their experimental limits intact.